54377-02-5
54377-02-5
Chemical Structure
L-Octanoylcarnitine hydrochloride
- CAS No.: 54377-02-5
- Formula:C15H30ClNO4
- Molecular Weight:323.86
IUPAC Name: (R)-3-carboxy-N,N,N-trimethyl-2-(octanoyloxy)propan-1-aminium chloride
InChIKey: MYMFUYYXIJGKKU-BTQNPOSSSA-N
SMILES: CCCCCCCC(O[C@H](CC(O)=O)C[N+](C)(C)C)=O.[Cl-]
Biological Activity: L-Octanoylcarnitine hydrochloride is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine hydrochloride can be used for the research of breast cancer[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Octanoylcarnitine hydrochloride | 98.0% | L-Octanoylcarnitine hydrochloride is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine hydrochloride can be used for the research of breast cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Octanoylcarnitine hydrochloride (Standard) | ≥98% | L-Octanoylcarnitine (hydrochloride) (Standard) is the analytical standard of L-Octanoylcarnitine (hydrochloride) (HY-W354498). This product is intended for research and analytical applications. L-Octanoylcarnitine hydrochloride is a plasma metabolite and a physiologically active form of octanoylcarnitine. L-Octanoylcarnitine hydrochloride can be used for the research of breast cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Octanoyl-L-carnitine-d3 chloride | 99.94% | Octanoyl-L-carnitine-d3 (chloride) is the deuterium labeled Octanoyl-L-carnitine chloride. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Schönfeld P, Reiser G. Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration. J Cereb Blood Flow Metab. 2017 Mar;37(3):848-854. [Content Brief]
- [2]. Hanna Kosnik, et al. CHRONIC HIGH FAT DIET IMPAIRS DETRUSOR MITOCHONDRIAL FATTY ACID OXIDATION IN MALE BUT NOT FEMALE MICE. Journal of UrologyBladder & Urethra: Anatomy, Physiology & Pharmacology I (MP11)1 Apr 2019.
- [3]. Kim M, et al. Association between arterial stiffness and serum L-octanoylcarnitine and lactosylceramide in overweight middle-aged subjects: 3-year follow-up study. PLoS One. 2015 Mar 17;10(3):e0119519. [Content Brief]
